An Act relative to toxic-free medical additives reforming your health
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill aims to reduce the use of certain phthalates, specifically DEHP, in intravenous solution containers and tubing sold in Massachusetts. It establishes a timeline for phasing out the intentional addition of these chemicals, starting with intravenous solution containers in 2030 and intravenous tubing in 2035. The bill includes exemptions for certain blood collection products and provides a transition period for manufacturers facing FDA approval delays or equipment limitations.
Key provisions
- Establishes a timeline for phasing out intentional addition of DEHP in intravenous solution containers (2030).
- Establishes a timeline for phasing out intentional addition of DEHP in intravenous tubing (2035).
- Sets a limit of 0.1 percent w/w for unintentionally added DEHP in these products.
- Exempts certain blood collection and storage bags and kits.
- Provides a transition period for manufacturers facing FDA approval delays or equipment limitations.
- Defines key terms related to phthalates and medical devices.
- Requires notification to customers regarding DEHP-free development efforts.
- Specifies a deadline for notifying customers of non-compliance with the phase-out timeline.
Who is affected
- Manufacturers of intravenous solution containers and tubing
- Healthcare facilities utilizing intravenous solutions and tubing
- Patients receiving intravenous treatments
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
1 on record
Primary sponsor
Joint Committee on Health Care Financing
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours